0001732150-24-000001.txt : 20240220
0001732150-24-000001.hdr.sgml : 20240220
20240220100340
ACCESSION NUMBER: 0001732150-24-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
EFFECTIVENESS DATE: 20240220
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vektor Medical, Inc.
CENTRAL INDEX KEY: 0001732150
ORGANIZATION NAME:
IRS NUMBER: 820798484
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-505570
FILM NUMBER: 24651250
BUSINESS ADDRESS:
STREET 1: 7875 SITIO ABETO
CITY: CARLSBAD
STATE: CA
ZIP: 92009
BUSINESS PHONE: 858-405-0094
MAIL ADDRESS:
STREET 1: 7875 SITIO ABETO
CITY: CARLSBAD
STATE: CA
ZIP: 92009
D
1
primary_doc.xml
X0708
D
LIVE
0001732150
Vektor Medical, Inc.
9255 Towne Centre Drive
Suite 750
San Diego
CA
CALIFORNIA
92121
858-405-0094
DELAWARE
None
None
Corporation
true
Robert
J.
Krummen
9255 Towne Centre Drive
Suite 750
San Diego
CA
CALIFORNIA
92121
Executive Officer
Director
Alexander
M.
Monko
9255 Towne Centre Drive
Suite 750
San Diego
CA
CALIFORNIA
92121
Executive Officer
Director
Douglas
S.
Komen
9255 Towne Centre Drive
Suite 750
San Diego
CA
CALIFORNIA
92121
Executive Officer
Lana
Caron
9255 Towne Centre Drive
Suite 750
San Diego
CA
CALIFORNIA
92121
Executive Officer
Chris
Villongco
9255 Towne Centre Drive
Suite 750
San Diego
CA
CALIFORNIA
92121
Executive Officer
Joe
Braidwood
9255 Towne Centre Drive
Suite 750
San Diego
CA
CALIFORNIA
92121
Executive Officer
Luc
Marengere
9255 Towne Centre Drive
Suite 750
San Diego
CA
CALIFORNIA
92121
Director
C.
David
Adair
9255 Towne Centre Drive
Suite 750
San Diego
CA
CALIFORNIA
92121
Director
Shannon
St. Clair
9255 Towne Centre Drive
Suite 750
San Diego
CA
CALIFORNIA
92121
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2024-02-02
false
true
false
0
37498887
28898880
8600007
false
98
0
0
0
The figure above excludes ordinary compensation for services.
false
Vektor Medical, Inc.
Robert J. Krummen
Robert J. Krummen
CEO
2024-02-19